International Alliance for Cancer Early Detection PhD Studentship
4-year PhD programme in cancer early detection at University of Manchester
The International Alliance for Cancer Early Detection (ACED) is a partnership between Cancer Research UK, University College London, the Canary Center at Stanford University, the University of Cambridge, the Knight Cancer Institute at OHSU, and the University of Manchester.
Earlier detection of cancer offers the greatest opportunity to deliver improvements in successful outcomes for patients. By diagnosing cancer earlier, it is easier to treat, causing less suffering to patients and could save lives.
ACED has the bold ambition to accelerate and revolutionise research in the early detection of cancers by uniting world leading researchers to bring together the best early detection science across the UK and US.
We are seeking candidates with an outstanding academic record with a minimum upper second class or Master’s degree or equivalent in a discipline relevant to early detection research, including but not limited to: biochemistry/molecular biology, biophysics, computer science, engineering, epidemiology, public health, physics, mathematics, medicine.
Details of the Studentship
ACED is committed to training the next generation of early detection scientists and providing a supportive and flexible training environment. The ACED PhD programme provides unique support by offering a multi-disciplinary and multi-institutional approach to training.
The first year of the Programme allows the students to develop their project with their chosen Manchester supervisor as well as training in different disciplines relevant to cancer early detection. This will be followed by a 3-year research project.
ACED PhD students will also benefit from:
- Opportunities for rotations in different ACED Centres in the first year.
- Dedicated ACED Early Detection of Cancer training programme.
- Early Detection Summer School.
- Annual Early Detection of Cancer Conference.
Supervisor arrangements
Successful students will select their Principal Supervisor in a subject area of their choice from a list of approved Manchester ACED PhD Supervisors. The Principal Supervisor and student will co-develop the PhD research project during the first year of the Programme, including selecting a suitable co-supervisor with complementary expertise from another ACED Member Centre.
Funding
The funding for this studentship includes tuition fees at the UK home rate only (funding will not cover international fees). For eligible students, the studentship will provide tuition fees, running expenses and an annual maintenance stipend starting £22,113 funded by Cancer Research UK for up to 4 years, subject to satisfactory progress.
Eligibility
Due to funding restrictions, we will only be able to offer studentships to candidates that have UK “home” tuition fee status (i.e. UK National or have EU “pre-settled” or “settled” status), self-funding of the international portion of the tuition fee will not be eligible. For more information on home tuition fee status please visit the UKCISA website. Candidates must meet the Manchester entry requirements
How to apply
Applicants must demonstrate a strong interest in early detection of cancer research.
Applicants may only submit ONE application for an ACED PhD Studentship.
To apply please complete this online application form.
You will need to state in the application one Manchester ACED PhD supervisor from the list of approved Manchester ACED supervisors.
If you have any queries about this studentship or the application process, please contact Dr Martin Bone (martin.bone@manchester.ac.uk), Manchester ACED Programme Manager
Key dates:
- Application deadline: Monday 10th November 2025
- Interview date: February 2026
- Studentship start: October 2026
Navigation
Research Themes
ACED Manchester's research is prioritised across three key research themes and several disease sites.
ACED Funding Acknowledgment
Access the Communications Toolkit for researchers, students and projects funded through ACED
About ACED Manchester
ACED is a partnership between world-leading early detection institutes and organisations dedicated to improving the early detection of cancer.